N
Google TrendMICHAEL OLISE (500+) — Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:michael olise500+bank of america fine1000+club brugge200+rb leipzig200+anthony gordon500+mid atlantic ridge earthquakes500+montez sweat2000+rob lowe1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Akt Inhibitor Advancement" (30 stories)

Top Headline Story

TFCP2L1 suppresses breast cancer progression by promoting ferroptosis through direct and PI3K/AKT-mediated inhibition of GPX4
Lead StoryNaturegeneral
Jun 26

TFCP2L1 suppresses breast cancer progression by promoting ferroptosis through direct and PI3K/AKT-mediated inhibition of GPX4

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ya2d2cG8xN1pNNWJ1RVd5QnhaR2kwY0pBdElTangtRGExWHpRWW9nQngwNFdVeE9XNHNYai1ZdV9oZ3Nsd3lYTDlxc1BXRU93czc3c0NrZGRFNFhpWk5r?oc=5" target="_blank">TFCP2L1 suppresses breast cancer progression by promoting ferroptosis through direct and PI3K/AKT-mediated inhibition of GPX4</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+19m ago

michael olise

Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay

Filter stories
1000+19m ago

bank of america fine

Bank of America fined $1.2 billion over money-laundering violations

Filter stories
200+19m ago

club brugge

LIVE: Dan toch 1-1! Club laat zich na penalty Tresoldi te makkelijk vangen, Lautaro zorgt voor gelijkmaker

Filter stories
200+19m ago

rb leipzig

Nach 6:0 in der Liga: Demichelis erwartet anderes Kaliber

Filter stories

Search Results for "Akt Inhibitor Advancement"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises
ACS Publicationsgeneral

Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNUnJhUnc4UU9Qc3ZNNnVPdzlGU3R6Q0ltLVlKSmZjMDNKWFpxeFNUelBELWhyakxWMENEVEVrTGJ0S3loRWZUY3o5VUplM2ZKTXY5Rk1NNjZsUXdUS0REcmpFYWxMNkpwZGY3TkZyZmF4NDNhTWlsQlNMUTFOS0FucTRIX3RvdDRBWFJVeUtzeGVDV0ZiTkkxdkYzRS03QQ?oc=5" target="_blank">Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises</a>  <font color="#6f6f6f">ACS Publications</font>

Read Full StoryMore like this
Targeting the UFL1-AKT cascade suppresses triple-negative breast cancer progression
Naturegeneral

Targeting the UFL1-AKT cascade suppresses triple-negative breast cancer progression

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1qcFFFOTd3azBleE11TlBaNkY1SE5TWU95WElNN21JWWhMNVJYUWU2ZTdIWmRBRzBhMWpBNFdFY2dFUm42X2xEZkxuT3l4UWc3MjRnQXR5bTQyTy1nc3hj?oc=5" target="_blank">Targeting the UFL1-AKT cascade suppresses triple-negative breast cancer progression</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Terremoto Biosciences Closes $108 Million Series C Financing to Advance Selective AKT1-Inhibitors in Oncology and Hereditary Hemorrhagic Telangiectasia
Business Wirescience

Terremoto Biosciences Closes $108 Million Series C Financing to Advance Selective AKT1-Inhibitors in Oncology and Hereditary Hemorrhagic Telangiectasia

<a href="https://news.google.com/rss/articles/CBMitAJBVV95cUxNbWdSaFVmeTlBMTFxdldTc3hqekkxSDJiazZDUTlqdGF1YUNsd0NhVnpOZXFLajRib1V1aW82ZjRqYzBBWGN0Tk8tWWM5RjFBT21hcmw0aF9za1oxRWFlNGlNYzNuT0xPRFA3ODdwdHJ2alNsWE1Jd3RXOTNNdHNaUllmXzNUQkNTTW5sWWktMzQ0REkxQlFjYkNndzJsTUNkUTVQXzBWQWg2Z09CSGRYRTFQVzRnUDB5Zjd6TG5uZkNPbVR2VVpWNUpmRTlSQnpRWk16Ynl5UjNXWThSUVdUS1JfQlpjbThxM2p6TnItbUUzV1pheTdNVUQxek9XM2tTU0NwSGw2VkFnbUpKREVMT0JTcEZiYjRRV2FDUU1pd1o1cjlhdEVwSDdocllxakw5cVpHXw?oc=5" target="_blank">Terremoto Biosciences Closes $108 Million Series C Financing to Advance Selective AKT1-Inhibitors in Oncology and Hereditary Hemorrhagic Telangiectasia</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Atavistik Bio Holds $120 Million Series B Financing to Advance Small Molecule Therapies for HHT and MPNs
Pharmaceutical Executivegeneral

Atavistik Bio Holds $120 Million Series B Financing to Advance Small Molecule Therapies for HHT and MPNs

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOYlZvaW1jSFczNllTdW4zV1BPU2xWclJKUVRDcTN5NW9jUUN2TjZhM2FlR3hmcFM4WDZ0VFBPTG9MYlZiczR1N0RDTXE5b0xMSFFzRTg2ZW5ZbWVWZXVib2c5RndzbGgtY2QyN1pUY1ZULXJET3RTRFl6ekJnT3hQVGJKT0JfekJXWFA1ajRGTmdDUkhyaWQweWNPa1BMMzVodnFLUGVmVm9GdU9sR0lFZENXS0VGZ2ZBQ3BxMWRfOVVhYXEtLUJybUdSYw?oc=5" target="_blank">Atavistik Bio Holds $120 Million Series B Financing to Advance Small Molecule Therapies for HHT and MPNs</a>  <font color="#6f6f6f">Pharmaceutical Executive</font>

Read Full StoryMore like this
Exploring Capivasertib: A New AKT Inhibitor for Targeted Cancer Treatment
Science Partner Journalsgeneral

Exploring Capivasertib: A New AKT Inhibitor for Targeted Cancer Treatment

<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFBwQ2IyVzMzVTA5MENVczAxX2RaZm5qb19GcF9FT3MydEtGS01FcTZ2NHZVRzVfS0dsWVgxU3VwVzQwWVl0dTZSYl84NWZDM1psU0NBMjIxQkczMWcyM3gtT0h6VFhzdw?oc=5" target="_blank">Exploring Capivasertib: A New AKT Inhibitor for Targeted Cancer Treatment</a>  <font color="#6f6f6f">Science Partner Journals</font>

Read Full StoryMore like this
EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway
Frontiersgeneral

EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNdWZWcWhGS0lwUkpNSk1ZQVJhUy13TjI0aFNlUWZPYnZyUXZ4X0FRQm1GWVh0a1lSWnhRbjdyMU5jYnpMVWtmMTJWQTM3ZmhnTVBiVF9xZ0J0R2ZYakh3a3oxWWpfWjQyc2ZkcXJ3Sl9xZGVEU2tsNFZsSjdQS085aUtEUHJLMEpaeG5VbVBR?oc=5" target="_blank">EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Transcription factor targeting strategies in cancer: mechanisms, challenges and cutting-edge progress
Naturegeneral

Transcription factor targeting strategies in cancer: mechanisms, challenges and cutting-edge progress

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1Hb0lMNFFRWVMxTVp6TTIyMENwcDBEbXRHUTBNVE9UWDB5amc5OFlwWjQ2bGhlU1dZdjJTSlRFc0t5aXJxNElKbjFjbEFsWG1YMWF4YVczeWo4UTlvbTJr?oc=5" target="_blank">Transcription factor targeting strategies in cancer: mechanisms, challenges and cutting-edge progress</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
The Lancetgeneral

Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNVVCeUFrXzVrSmRZY0lSZWxYMTlteWZvVFZidVBSa1ctSTBKYWp6YW9PTlRVZ0QyY3o5TW5tTW9nNEVwZjJBMW9xWkJsa05VRDhxbXd6R3hjX3I1dGdwckZ2dmdWdDZQeXBiVkxxTFpBdzUtcFhZV1B0WUpmWGFjMHF1dlRKU0JzUnVN?oc=5" target="_blank">Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
CDC6/THBS1 accelerates pancreatic cancer progression via AKT-mediated glycolytic reprogramming
Naturegeneral

CDC6/THBS1 accelerates pancreatic cancer progression via AKT-mediated glycolytic reprogramming

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA1MFRiWlpiTTMyTUo3b2JWcmlQeExTNW12T291T3ZUNjdDZDA2VjE3RE1QUS1mR1JxVE5SMFVOOEw1SFc0TEZVUHl5ajd1dWlJOGJzX2RIb3RlV1BUVVZN?oc=5" target="_blank">CDC6/THBS1 accelerates pancreatic cancer progression via AKT-mediated glycolytic reprogramming</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
Frontiersgeneral

Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQSHE4aExKVHRzT0VUUFhxeWNSeWNtU0g2Y25yOFpfMUFUT0Q5NUNsUUJPbkZIMU5Ea3JYUXc4MkxWLXhPcFdKTklVVUE0bXRlRG9ueFVCSVRqWnpUYk1qS0FDQkNHOVpiaVl0dUdEMkY4aFdyVHZDWm1GT1BTZnJIei1zUVpUMWxqZGtSTjh5WThNN2M?oc=5" target="_blank">Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
MAPK6-AKT signaling promotes tumor growth and resistance to mTOR kinase blockade
Science | AAASgeneral

MAPK6-AKT signaling promotes tumor growth and resistance to mTOR kinase blockade

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE95UXlTSmVpemRRQkFjLTJYUng5VWpNYTNWSHRvNkdQZ25aVy1teV9zNXQ5cnp6N05qRzZUM1R3Z0xrQklLQ2hPQ3FkRkQ2UEFWbThrRG9qbV8zdlY0emMw?oc=5" target="_blank">MAPK6-AKT signaling promotes tumor growth and resistance to mTOR kinase blockade</a>  <font color="#6f6f6f">Science | AAAS</font>

Read Full StoryMore like this
Apatinib inhibits synovial sarcoma progression and angiogenesis via VEGFR2-mediated AKT/FOXO3A and ERK1/2/FOXM1 signaling pathways
Naturegeneral

Apatinib inhibits synovial sarcoma progression and angiogenesis via VEGFR2-mediated AKT/FOXO3A and ERK1/2/FOXM1 signaling pathways

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9lV3VhWGpIVnBxeWN4dzRzaVFwNzNNWkJBOTNBM28zZWdsWXBjUGhDWUFhZWwtT3dBRXJpUFhEZ2h6VVJpVHhfUGpaSG1mNTBUcEplWXJERFFUckI4R2sw?oc=5" target="_blank">Apatinib inhibits synovial sarcoma progression and angiogenesis via VEGFR2-mediated AKT/FOXO3A and ERK1/2/FOXM1 signaling pathways</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
PI3K/Akt in IPF: untangling fibrosis and charting therapies
Frontiersworld

PI3K/Akt in IPF: untangling fibrosis and charting therapies

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPNTlyN0V1Zl83LTA0YVdYcXpMdVU2US1lUEttMmczdWktQWxaakVfYnM1NUg4ZmpDTUllQ251VE1PSnVBZU54dlVJLWREcmFWZG5ELUxiVUxKa3ZsS2xNdUNNTFZFYXNKR3U5Q1dyQmxYS09oN1I0eGZpT0tSSGY1RHk0SXVnb0U1dm9PZEE1TDdkQQ?oc=5" target="_blank">PI3K/Akt in IPF: untangling fibrosis and charting therapies</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Recent Advances in the Treatment of Breast Cancer
Frontiersgeneral

Recent Advances in the Treatment of Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPYW9aVVRydDhFYUVWcWVJZ0UzYjIyOUV1RHBwQ2pIazF2Y3kzbi1faTlQTlZiaGxGWkJFVXg3cUpjVG41VEE5Q25kUldKRHRHTWM2bE8tbTJQV2I4UFpYSllNY19MTzF0WG9TdFJ1clRKbGp2VE01Um43ZkpMOUdBLTJnSXFaV2ZnNjhz?oc=5" target="_blank">Recent Advances in the Treatment of Breast Cancer</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma
Naturegeneral

PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBtaTVYbk5oUTRWN3M4TWdYeWo3MXpjejBnSHlLeGw3dHBPcDVfV2JtMmlSOWNGRkdMT3k4SDFaRnkxb29MdzlVX1JMZ3ctWW9Ud1dCODhtZ1JiNVhJZW04?oc=5" target="_blank">PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
miR-139-5p suppresses hepatocellular carcinoma progression by targeting SMOX to inhibit AKT-mTOR pathway and epithelial-mesenchymal transition
Naturegeneral

miR-139-5p suppresses hepatocellular carcinoma progression by targeting SMOX to inhibit AKT-mTOR pathway and epithelial-mesenchymal transition

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBTak92OE8zclduMzUzMHI1Q3g5LVdsbkljM3RzdHpaS1BiQlRUWVhJR2F0eTl1OWZ4RjU1VHNTalA0NE5qYmZoUDB1S19VR0pqYjZxQ2tNVWh2T3FSUGlJ?oc=5" target="_blank">miR-139-5p suppresses hepatocellular carcinoma progression by targeting SMOX to inhibit AKT-mTOR pathway and epithelial-mesenchymal transition</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
UCHL3 depletion inhibits gastric cancer progression and enhances palbociclib sensitivity by regulating the AKT/CCND1 signaling axis via ENO1 ubiquitination | Cell Death & Disease
Naturegeneral

UCHL3 depletion inhibits gastric cancer progression and enhances palbociclib sensitivity by regulating the AKT/CCND1 signaling axis via ENO1 ubiquitination | Cell Death & Disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAtZ1JwMkxKMUdwUHFYNUlEXzlKRkVfdnc3QXhMUzlkbmFsRUlidDdHMlFQanRrRUJoTW1iRkpSTnNKZGlNWHJ0bHZWbHVGRHA1Q3lGbWN4Yzk3emJ1VVVJ?oc=5" target="_blank">UCHL3 depletion inhibits gastric cancer progression and enhances palbociclib sensitivity by regulating the AKT/CCND1 signaling axis via ENO1 ubiquitination | Cell Death & Disease</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
RAD18 facilitates cancer progression and immunosuppression via the AKT/mTOR/c-Myc axis: a multi-omics analysis
Natureworld

RAD18 facilitates cancer progression and immunosuppression via the AKT/mTOR/c-Myc axis: a multi-omics analysis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9JcWVleDd6ODFMdTdoTHVjU2lJN1EzZ21rWXlBRHpwOGxWUVZMcEFqdzhaeU9naU4wd25Ga2swbkhmVlFFb0k1LVZScjJ0ZG42NXhIVjZRQkEteEpaM1lB?oc=5" target="_blank">RAD18 facilitates cancer progression and immunosuppression via the AKT/mTOR/c-Myc axis: a multi-omics analysis</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
Naturegeneral

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1XOWNRbHIyOGdIdFhUNk0zYmhGbzRwNHQ3NV9mVHhsei15NHhLR2l4ZmVFVzNHOXI3ak5mOVQ5WEJ4MW8yTzdCeWJHWUxySURUNU1RV3Z2N3plVjQtZTNj?oc=5" target="_blank">USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway
Naturegeneral

MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE93cUt1TUEzTVV5cTluTF9YaTlZTUNpRDRLYjM1QV9HaVhubXN0eWk3ZXVQZWg1bk1mbzd5dmMtajhmLXYzUU1xdkt1amE4Z1kwVHNUV2hXdkwtNHZYYmh3?oc=5" target="_blank">MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse
Science | AAASgeneral

Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBOY25NdVF3UlVRVnFkSGFlYnFyVFVYODVQNkF1ekNhVHZVR3d4d0V2UTNEYjhhSjdKdnY4QzFweFBuM1ZjMlNmSjhoWGIwUXdSODkzeGtSRHQ0UUVmQ3Nz?oc=5" target="_blank">Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse</a>  <font color="#6f6f6f">Science | AAAS</font>

Read Full StoryMore like this
Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy
Frontiersgeneral

Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOaC1BajVjcXd3TE0tNm5sVWJyMnZ0SXhqU1lIYk9BTWNfV3BoS1R4amt3ZmMxek5GMm90dGxIMEJVY0lxY0t1aWJsbDR0bFNBZGdnNGg2cW9rMWRaRzF4M013YjVpcF94ZnEyQklWRndwcUZpV3V6Z0lxN0hJZ0dPdTdCX3JGTUVKLTJuYmNB?oc=5" target="_blank">Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway
Naturegeneral

Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ERUE5Y0g0Qm0zWTg3RGFvVHp1ZlB6akhLMHYwTFYtZExvckhYS1ZTNzFxU3NvN2tEdE9qOFA1YmNXTDNTNTZXem40M1BBWEwxbTBmR29jakludmg4dFJr?oc=5" target="_blank">Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Kinase drug discovery 20 years after imatinib: progress and future directions
Naturegeneral

Kinase drug discovery 20 years after imatinib: progress and future directions

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9uUmEzcGVVcXRrUDJKS1RfaDFXZlRuMFA3b1U3QU9KRm9sTUJrTHlyTjBCV1FUTWFhZllyaDFMN0pWTEVkMVZYR1ExLXFJOUVLVDhGMFR2UGJEUkhVdFRn?oc=5" target="_blank">Kinase drug discovery 20 years after imatinib: progress and future directions</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K/AKT pathway | Cell Death & Disease
Naturegeneral

NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K/AKT pathway | Cell Death & Disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBNU2dxVlpPNGgzdVpWSTh5YjhaY05tOGo5dmZJaGdXR0lBNFNpeWc5RWhJX0xob2RIbk9pU1RKS1pfRlIzdWYtS2taQWpXVnc3TmFjVExDcnlaako0NmtF?oc=5" target="_blank">NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K/AKT pathway | Cell Death & Disease</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway
Naturegeneral

Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1RYndXZlpfTmVHaEJibmJRem91YldmR1NTb1dNUmd5T20yb0dpYnJabnJxQUdhOWZOQkh5WTdNdUtENDFlUmdFSjVpc3RVYU5ZcUhBOFlScDBOTE1XUG04?oc=5" target="_blank">Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation
Naturegeneral

Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5yMlF1SWdqdzBYUktrSFZDV1pWZ0ppakdseF9QLVdac29BeGI3cG9QRFF2dFU5UnBYYmFTUlVNODBXS2xOaG50MXJWRTVCa2w4YWZsNzg5bFNMWURGc3d3?oc=5" target="_blank">Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
Naturegeneral

Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBTeC1fUXF6Y2oyR1BSX0dST0dpZERHRjNYV2xyZnVqekctY3ppZ2RmMS1UYWNURU0yUnNuMzZaMVZzdkFmeXhzZFhzR3psTnZlSEFjR18wY19oWEtnR1hZ?oc=5" target="_blank">Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
TCP1 promotes the progression of malignant tumours by stabilizing c-Myc through the AKT/GSK-3β and ERK signalling pathways | Communications Biology
Natureworld

TCP1 promotes the progression of malignant tumours by stabilizing c-Myc through the AKT/GSK-3β and ERK signalling pathways | Communications Biology

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9uOTRRcG5XOEtoa0NubG1wQVlmVHI1RzV2cjd4aWo0QVNHLXBEZGEzS21ILUtLVFd2anU1WXBxQkQ3NkVLMENZNUFNWTdjWW15SFJiV2ViX2JtZUJ5X1RZ?oc=5" target="_blank">TCP1 promotes the progression of malignant tumours by stabilizing c-Myc through the AKT/GSK-3β and ERK signalling pathways | Communications Biology</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
"Akt Inhibitor Advancement" — Live Google News Trends & Headlines